Sunway Medical Centre
Sunway Medical Centre aims to be a leading medical centre in Malaysia and in the ASEAN region. We strive to create a world-class medical centre with expertise, skills and equipment that match and outperform the best hospitals in the world. This is apparent by the number of recognitions we have received, both locally and internationally. And, we continue to record excellent results in various clinical parameters.
International Hospital of the Year 2017 - A Hospital with Multiple Global Recognitions
Sunway Medical Centre has been chosen as the Medical Tourism Hospital of the Year in Asia Pacific in 2018 by The Global Health & Travel Awards, as well as the International Hospital of the Year in 2017 by the International Medical Travel Journal.
This honour speaks volume about our commitment to provide the best healthcare treatment and care to our patients, regardless of where they come from.
Whether you are from Malaysia, Indonesia or Saudi Arabia, we will make sure you receive the best treatment and care from us. We also have an International Patient Centre (IPC) which is developed as a dedicated service to assist our international patients in seeking medical services in Kuala Lumpur. Our team also comprises of Chinese, Arabic, Japanese & Indonesian translators to help our international patients to navigate Sunway Medical Centre.
To provide international patient a safer care during the COVID-19 pandemic, the hospital has invested huge amount of efforts to upgrades its facilities and ensure the safety of frontline healthcare workers. The Hospital has attained the certificate of conformance for COVID-19 Guidelines for Medical Travel Program by Global Healthcare Accreditation (GHA).
Sunway Medical Centre aims to be a leading medical centre in Malaysia and in the ASEAN region. We strive to create a world-class medical centre with expertise, skills and equipment that match and outperform the best hospitals in the world.
As a hospital with experienced and dedicated doctors, we continuously work to match and outperform global and national standards. These global and national standards affirm the high quality and standards of care that we provide to our patients.
Malaysia Society for Quality & Health (MSQH)
Sunway Medical Centre has been accredited nationally by MSQH since 2013. The MSQH accreditation promotes and improves safety and quality in the provision of healthcare services in Malaysia based on its standards.
Australian Council Healthcare Standards (ACHS)
We are the first hospital in Southeast Asia to receive international accreditation from the Australian Council on Healthcare Standards since 2014. This accreditation shows that our hospital matches the high standards used in Australia.
Explore Our Clinical and Quality Improvement Data
To ensure our hospital upholds the highest standards of patient safety for all patients, we monitor KPIs as part of our quality improvement activities to ensure high-quality care is given to all patients.
Clinical Outcomes
Our survival rate for patients who underwent a kidney transplant after 6 months and 12 months is 100%, higher than global predicted survival rate of 92% - 97%.
| Measures | Target | Achievement | |
| 2022 | 2023 | ||
| Survival rate renal transplant ≥ 6 months | 100% |
 100% |
100% |
| Survival rate renal transplant ≥ 12 months | 100% |
100% |
100% |
Indication:
Met target 
Not met target
We've performed over 400 TKR surgeries in 2023. Our services not only assure the patient's safety during the surgery, but we also prioritise care and therapy following surgery.
| Measures | Target | Achievement | |
| 2022 | 2023 | ||
| Percentage of patients receiving anti-embolic therapies post TKR day 1 | > 90% | Not Monitored |
95% |
| Surgical site infection rate for post-total knee replacement | 0% |
0% |
0% |
Indication:
Met target Not met target
Our one-stop cancer centre has been established since 2016. We strive to do everything possible to ensure that our patients receive high-quality cancer diagnosis, treatment, and care.
Nasopharyngeal Cancer (NPC) Clinical Outcome
Non-Small Cell Lung Cancer Clinical Outcome
| Measures | Benchmarking American Cancer Society | Achievement in 2016 - 2018 |
| 5-year relative survival rate of stage III non-small cell lung cancer | 37% |
40% |
Indication:
Met target Not met target
Our maternity ward strives to ensure expectant moms have a safe delivery in Sunway Medical Centre. Hence, we are monitoring KPIs in the maternity ward to ensure that high quality care is given to all patients.
| Measures | Target | Achievement | |
| 2022 | 2023 | ||
| Maternal mortality rate | 0% |
0% |
0% |
| Incidence of 3rd and 4th degree perineal tear following vaginal delivery | 0% |
0% |
0% |
Indication:
Met target Not met target
These measures are benchmarked with various Australian hospitals registered under the Australia Council Healthcare Society (ACHS).
| Measures | Target | Achievement | |
| 2022 | 2023 | ||
| Post-polypectomy complication (bleeding) | 0% |
0% |
0% |
| Oesophagus perforation secondary to oesophagus dilatation procedure | 0% |
0% |
0% |
Indication:
Met target Not met target
Infection Prevention & Control
Patient safety and high-quality care have always been our priority. In Sunway Medical Centre, an infection control team collects data on hospital-acquired infections (HAI) to ensure we can control the spread of infection by adhering to stringent infection control practices.
What Is a Hospital-Acquired Infection?
Hospital-acquired infection (HAI) is an infection that you may get during your hospitalisation. In Sunway Medical Centre, our HAI rate is lower than the universal rate. We are benchmarking our data with the Centers for Disease Control and Prevention (CDC).
| Measures | Target | Achievement | |
| 2022 | 2023 | ||
| Hospital-acquired infection (HAI) rate | < 5% |
0.06% |
0.07% |
Breakdown of HAI
The data below are the subsets of hospital-acquired infection. The lower rate implies our dedicated team deliver care and treatment based on the best practices. Our target is benchmarked with the national accreditation.
| Measures | Target | Achievement | |
| 2022 | 2023 | ||
| Ventilator-associated pneumonia (VAP) | < 10 per 1,000 ventilated-days |
3.36 |
4.12 |
| Catheter blood stream infection (CRBSI) | < 5 per 1,000 catheter-days |
0.6 |
0.81 |
| Surgical site infection (clean elective surgeries) | < 2% |
0.6 |
0.1 |
Indication:
Met target Not met target
Data validated by Quality Resources
